Related references
Note: Only part of the references are listed.The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data
N. M. Anstey et al.
LANCET INFECTIOUS DISEASES (2015)
Benefits of a Pharmacology Antimalarial Reference Standard and Proficiency Testing Program Provided by the Worldwide Antimalarial Resistance Network (WWARN)
Chris Lourens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Population Pharmacokinetics and Clinical Response for Artemether-Lumefantrine in Pregnant and Nonpregnant Women with Uncomplicated Plasmodium falciparum Malaria in Tanzania
Dominic Mosha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
The double burden household in sub-Saharan Africa: maternal overweight and obesity and childhood undernutrition from the year 2000: results from World Health Organization Data (WHO) and Demographic Health Surveys (DHS)
Janet M. Wojcicki
BMC PUBLIC HEALTH (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment
Mohammed Lamorde et al.
AIDS (2013)
Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial
Birgit Schramm et al.
MALARIA JOURNAL (2013)
Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia
Birgit Schramm et al.
MALARIA JOURNAL (2013)
Malaria Burden and Artemisinin Resistance in the Mobile and Migrant Population on the Thai-Myanmar Border, 1999-2011: An Observational Study
Verena I. Carrara et al.
PLOS MEDICINE (2013)
Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda
F. Kloprogge et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Concomitant Efavirenz Reduces Pharmacokinetic Exposure to the Antimalarial Drug Artemether-Lumefantrine in Healthy Volunteers
Liusheng Huang et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults
Pauline Byakika-Kibwika et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Aung Pyae Phyo et al.
LANCET (2012)
Antiretroviral Agents and Prevention of Malaria in HIV-Infected Ugandan Children
Jane Achan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Determination of lumefantrine in small-volume human plasma by LC-MS/MS: using a deuterated lumefantrine to overcome matrix effect and ionization saturation
Liusheng Huang et al.
BIOANALYSIS (2012)
Effect of Nutritional Status on Response to Treatment with Artemisinin-Based Combination Therapy in Young Ugandan Children with Malaria
Wendy J. Verret et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pharmacokinetic and Pharmacodynamic Characteristics of a New Pediatric Formulation of Artemether-Lumefantrine in African Children with Uncomplicated Plasmodium falciparum Malaria
Abdoulaye A. Djimde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Artemether, Lumefantrine, and Their Respective Metabolites in Papua New Guinean Children with Uncomplicated Malaria
Sam Salman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Desbutyl-Lumefantrine Is a Metabolite of Lumefantrine with Potent In Vitro Antimalarial Activity That May Influence Artemether-Lumefantrine Treatment Outcome
Rina P. M. Wong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Efficacy and Effectiveness of Artemether-Lumefantrine after Initial and Repeated Treatment in Children < 5 Years of Age with Acute Uncomplicated Plasmodium falciparum Malaria in Rural Tanzania: A Randomized Trial
Billy E. Ngasala et al.
CLINICAL INFECTIOUS DISEASES (2011)
Similar Efficacy and Tolerability of Double-Dose Chloroquine and Artemether-Lumefantrine for Treatment of Plasmodium falciparum Infection in Guinea-Bissau: A Randomized Trial
Johan Ursing et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study
Billy E. Ngasala et al.
MALARIA JOURNAL (2011)
A new world malaria map: Plasmodium falciparum endemicity in 2010
Peter W. Gething et al.
MALARIA JOURNAL (2011)
Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan Coast
Steffen Borrmann et al.
PLOS ONE (2011)
Pharmacokinetics of Artemether-Lumefantrine and Artesunate-Amodiaquine in Children in Kampala, Uganda
Julia Mwesigwa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Population Pharmacokinetics and Pharmacodynamics of Artemether and Lumefantrine during Combination Treatment in Children with Uncomplicated Falciparum Malaria in Tanzania
Sofia Friberg Hietala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vivo Parasitological Measures of Artemisinin Susceptibility
Kasia Stepniewska et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial
Patrice Piola et al.
LANCET INFECTIOUS DISEASES (2010)
Population Pharmacokinetics of Lumefantrine in Pregnant Women Treated with Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria
Joel Tarning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma
E. M. Hodel et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Comparison of Sulfadoxine-Pyrimethamine, Unsupervised Artemether-Lumefantrine, and Unsupervised Artesunate-Amodiaquine Fixed-Dose Formulation for Uncomplicated Plasmodium falciparum Malaria in Benin: A Randomized Effectiveness Noninferiority Trial
Jean-Francois Faucher et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance
Nicholas J. White et al.
MALARIA JOURNAL (2009)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pathophysiological changes that affect drug disposition in protein-energy malnourished children
Kazeem A. Oshikoya et al.
NUTRITION & METABOLISM (2009)
Residual Antimalarials in Malaria Patients from Tanzania - Implications on Drug Efficacy Assessment and Spread of Parasite Resistance
Eva Maria Hodel et al.
PLOS ONE (2009)
The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria
Sue J. Lee et al.
MALARIA JOURNAL (2008)
A Trial of Combination Antimalarial Therapies in Children from Papua New Guinea
Harin A. Karunajeewa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh:: a randomised controlled trial
Md. Mushfiqur Rahman et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Simplified antimalarial therapeutic monitoring: using the day-7 drug level?
Nicholas J. White et al.
TRENDS IN PARASITOLOGY (2008)
A Randomised Controlled Trial of Artemether-Lumefantrine Versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy
Rose McGready et al.
PLOS MEDICINE (2008)
Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper
D. Blessborn et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
World antimalarial resistance network (WARN) IV: Clinical pharmacology
Karen I. Barnes et al.
MALARIA JOURNAL (2007)
Combination therapy for uncomplicated falciparum malaria in Ugandan children - A randomized trial
Grant Dorsey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
Elizabeth A. Ashley et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria
Rose McGready et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia
Mey Bouth Denis et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda
Francesco Checchi et al.
MALARIA JOURNAL (2006)
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria
RN Price et al.
CLINICAL INFECTIOUS DISEASES (2006)
High throughput assay for the determination of lumefantrine in plasma
A Annerberg et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Development and validation of a bioanalytical method using automated solid-phase extraction and LC-UV for the simultaneous determination of lumefantrine and its desbutyl metabolite in plasma
N Lindegårdh et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2005)
Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda:: a randomised trial
P Piola et al.
LANCET (2005)
Modelling clustered survival data from multicentre clinical trials
DV Glidden et al.
STATISTICS IN MEDICINE (2004)
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic
JM Stohrer et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic
M Mayxay et al.
CLINICAL INFECTIOUS DISEASES (2004)
Effect of iron supplementation on incidence of infectious illness in children: systematic review
T Gera et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Micronutrient malnutrition and the pathogenesis of malarial anemia
V Nussenblatt et al.
ACTA TROPICA (2002)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Pharmacokinetic interaction trial between co-artemether and mefloquine
G Lefèvre et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2000)
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria
F Ezzet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria
M van Vugt et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2000)
Share Paper
